Axsome Therapeutics Announces Publication of Pivotal ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder in The American Journal of Psychiatry

  • Dan Vlad Iosifescu

Press/Media

Period18 May 2022

Media coverage

35

Media coverage